FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

425953004: Amphotericin B lipid complex (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661306016 Amphotericin B lipid complex (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2673402011 Amphotericin B lipid complex en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Amphotericin B lipid complex (substance) Is a Amphotericin B false Inferred relationship Some
Amphotericin B lipid complex (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Amphotericin B false Inferred relationship Some
Amphotericin B lipid complex (substance) Is a Amphotericin (substance) true Inferred relationship Some
Amphotericin B lipid complex (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antifungal true Inferred relationship Some
Amphotericin B lipid complex (substance) Is a Liposomal agent (substance) true Inferred relationship Some
Amphotericin B lipid complex (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Amphotericin B liposome (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Amphotericin b 5mg/mL infusion solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B lipid complex (substance) Inferred relationship Some
Product containing only amphotericin B lipid complex (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B lipid complex (substance) Inferred relationship Some 1
Amphotericin B lipid complex only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B lipid complex (substance) Inferred relationship Some 1
Product containing precisely amphotericin B lipid complex 5 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amphotericin B lipid complex (substance) Inferred relationship Some 1
Product containing precisely amphotericin B lipid complex 5 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amphotericin B lipid complex (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start